Kurt Banz

562 total citations
30 papers, 431 citations indexed

About

Kurt Banz is a scholar working on Epidemiology, Economics and Econometrics and Surgery. According to data from OpenAlex, Kurt Banz has authored 30 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Economics and Econometrics and 7 papers in Surgery. Recurrent topics in Kurt Banz's work include Herpesvirus Infections and Treatments (8 papers), Hepatitis Viruses Studies and Epidemiology (7 papers) and Coronary Interventions and Diagnostics (6 papers). Kurt Banz is often cited by papers focused on Herpesvirus Infections and Treatments (8 papers), Hepatitis Viruses Studies and Epidemiology (7 papers) and Coronary Interventions and Diagnostics (6 papers). Kurt Banz collaborates with scholars based in Germany, United States and Italy. Kurt Banz's co-authors include Peter Wutzler, Stefan Wagenpfeil, A Goertz, A. Neiß, Thomas Hammerschmidt, Jens Vollmar, Angela Bechini, Sara Boccalini, Ulrich Heininger and Paolo Bonanni and has published in prestigious journals such as Vaccine, Clinical Microbiology and Infection and Lung Cancer.

In The Last Decade

Kurt Banz

27 papers receiving 417 citations

Peers

Kurt Banz
Schmid Switzerland
Hilde Vroling United States
Santiago M. C. Lopez United States
R. F. Schumacher Italy
Laura Cámpora Belgium
Jo McAnerney South Africa
Goran Benčina Spain
Xavier Bresse France
Nicola Schinaia Italy
Hanna Czajka Poland
Schmid Switzerland
Kurt Banz
Citations per year, relative to Kurt Banz Kurt Banz (= 1×) peers Schmid

Countries citing papers authored by Kurt Banz

Since Specialization
Citations

This map shows the geographic impact of Kurt Banz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Banz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Banz more than expected).

Fields of papers citing papers by Kurt Banz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Banz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Banz. The network helps show where Kurt Banz may publish in the future.

Co-authorship network of co-authors of Kurt Banz

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Banz. A scholar is included among the top collaborators of Kurt Banz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Banz. Kurt Banz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Hancock, Rebecca, Christopher M. Feindel, Josep Rodés‐Cabau, et al.. (2013). Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. Journal of Medical Economics. 16(4). 566–574. 31 indexed citations
4.
5.
Banz, Kurt, et al.. (2009). Economic evaluation of varicella vaccination in Swiss children and adolescents. Human Vaccines. 5(12). 847–857. 22 indexed citations
6.
Bonanni, Paolo, Sara Boccalini, Angela Bechini, & Kurt Banz. (2008). Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: The burden of uncomplicated hospitalised cases. Vaccine. 26(44). 5619–5626. 24 indexed citations
7.
8.
Banz, Kurt, et al.. (2004). The burden of varicella in Germany. The European Journal of Health Economics. 5(1). 46–53. 36 indexed citations
9.
Wagenpfeil, Stefan, A. Neiß, Kurt Banz, & Peter Wutzler. (2004). Empirical data on the varicella situation in Germany for vaccination decisions. Clinical Microbiology and Infection. 10(5). 425–430. 39 indexed citations
10.
Hammerschmidt, Thomas, et al.. (2003). Validation of Health Economic Models: The Example of EVITA. Value in Health. 6(5). 551–559. 33 indexed citations
11.
Banz, Kurt, Stefan Wagenpfeil, A. Neiß, et al.. (2003). The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine. 21(11-12). 1256–1267. 75 indexed citations
12.
Pusich, Benjamin, et al.. (2002). Ökonomische Analysen in der Interventionellen Radiologie. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 174(2). 149–159. 2 indexed citations
13.
Wutzler, Peter, et al.. (2002). Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany. Medical Microbiology and Immunology. 191(2). 89–96. 33 indexed citations
14.
Duda, Stephan H., Gunnar Tepe, Mohan Bala, et al.. (2002). Economic Value of Thrombolysis with Adjunctive Abciximab in Patients with Subacute Peripheral Arterial Occlusion. PharmacoEconomics. 20(3). 203–213. 2 indexed citations
15.
Banz, Kurt, et al.. (1999). IR8: COST-EFFECTIVENESS OF COMBINED HEPATITIS A AND B VACCINATION AND HEPATITIS B MONOVACCINATION IN SWITZERLAND AND AUSTRIA. Value in Health. 2(5). 359–359. 1 indexed citations
16.
17.
18.
Banz, Kurt, et al.. (1997). Cost-Effectiveness of Palmaz-Schatzª Stenting in Patients with Coronary Artery Disease in The Netherlands.. PubMed. 9 Suppl A. 35A–40A. 3 indexed citations
19.
Banz, Kurt, et al.. (1997). New Perspectives on the Cost-Effectiveness of Palmaz-Schatzª Coronary Stenting, Balloon Angioplasty, and Coronary Artery Bypass Surgery Ñ A Decision Model Analysis.. PubMed. 9 Suppl A. 7A–16A. 2 indexed citations
20.
Banz, Kurt, et al.. (1994). Economic Evaluation of Immunoprophylaxis in Children with Recurrent Ear, Nose and Throat Infections. PharmacoEconomics. 6(5). 464–477. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Schmid Breakdown of academic impact, for papers by Hilde Vroling Breakdown of academic impact, for papers by Santiago M. C. Lopez Breakdown of academic impact, for papers by R. F. Schumacher Breakdown of academic impact, for papers by Laura Cámpora Breakdown of academic impact, for papers by Jo McAnerney Breakdown of academic impact, for papers by Goran Benčina Breakdown of academic impact, for papers by Xavier Bresse Breakdown of academic impact, for papers by Nicola Schinaia Breakdown of academic impact, for papers by Hanna Czajka
Rankless by CCL
2026